Precision medicine approaches to lung adenocarcinoma with concomitant MET and HER2 amplification

Biochemistry, Genetics and Molecular Biology

• Epidermal Growth Factor Receptor 100%
• Genetics 50%
• Next Generation Sequencing 50%
• Array Comparative Genomic Hybridization 50%
• Oncogene 50%
• Copy Number Analysis 50%
• Microarrays 50%
• Cell Growth 50%
• Tyrosine Kinase Inhibitor 50%
• Receptor Tyrosine Kinase 50%
• Drug Screening 50%
• Genomics 50%
• Crizotinib 50%

Medicine and Dentistry

• Xenograft 100%
• Personalized Medicine 100%
• Lung Adenocarcinoma 100%
• Neoplasm 42%
• Lung Cancer 42%
• Malignant Neoplasm 28%
• Targeted Therapy 28%
• In Vitro 14%
• Cancer Therapy 14%
• Epidermal Growth Factor Receptor 14%
• Cell Growth 14%
• Protein Tyrosine Kinase 14%
• Oncogene 14%
• Next Generation Sequencing 14%
• Tumor Xenograft 14%
• Drug Screening 14%
• Tyrosine-Kinase Inhibitor 14%
• EGFR Inhibitors 14%
• Array Comparative Genomic Hybridization 14%